Abstract
Periperative infliximab and/or immunomodulator therapy is not associated with increased postoperative complications in Crohn's disease
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s0016-5085(03)82635-5
Journal: Gastroenterology | Publication Date: Apr 1, 2003 |
Citations: 3 |
Periperative infliximab and/or immunomodulator therapy is not associated with increased postoperative complications in Crohn's disease
Join us for a 30 min session where you can share your feedback and ask us any queries you have